This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Johns Hopkins University. Active years: 2014-2016.
Company Filing History:
Years Active: 2014-2016
Title: Innovations by Ronald A Li: Pioneering Bio-Electrical Rhythm Modulation
Introduction
Ronald A Li is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of bioengineering, particularly in the modulation of bio-electrical rhythms. With a total of 2 patents, his work focuses on innovative approaches to enhance physiological responses in various cells.
Latest Patents
Li's latest patents include groundbreaking inventions that relate to the modulation of bio-electrical rhythms. These inventions involve novel compositions and methods designed to induce and/or modulate bio-electrical rhythms in cardiac, neuronal, and pancreatic cells. By fine-tuning the activity of HCN-encoded pacemaker channels through advanced protein and genetic engineering techniques, his inventions aim to augment or attenuate physiological responses such as heartbeats, neuronal firing, and insulin secretion. These innovations hold promise for therapeutic applications in conditions like sick sinus syndrome, epilepsy, neuropathic pain, and diabetes.
Career Highlights
Ronald A Li is affiliated with Johns Hopkins University, where he continues to push the boundaries of bioengineering. His research has garnered attention for its potential to transform treatment methodologies in various medical fields.
Collaborations
Li has collaborated with notable professionals in his field, including Eduardo Marban and Suk-Ying Tsang. These partnerships have further enriched his research and contributed to the advancement of innovative solutions in bioengineering.
Conclusion
Ronald A Li's work exemplifies the intersection of engineering and medicine, showcasing how innovative approaches can lead to significant advancements in healthcare. His contributions to the modulation of bio-electrical rhythms are paving the way for new therapeutic strategies.
